CSL Behring

HIZENTRA

  1. Home
  2.  / 
  3. J Code
  4.  / HIZENTRA – J1559

Manufacturer:

CSL Behring

Name:

HIZENTRA

HCPCS Code Descriptor:

Injection, immune globulin (hizentra), 100 mg

Category:

J Code

HCPCS:

J1559

NDC(s):

44206-0458-24, 44206-0455-10, 44206-0456-21, 44206-0457-22, 44206-0451-01, 44206-0452-02, 44206-0454-04

Primary Type:

Immunoglobulin

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

HIZENTRA is an Immunoglobulin drug manufactured by CSL Behring and administered via the Subcutaneous route of administration. The J Code: J1559 is aligned to the drug HIZENTRA.

Hizentra is used to aid the body's immune system in defense against infection using antibodies from healthy human blood plasma. This drug is administered via subcutaneous infusion as opposed to intravenous infusion. This means that patients are able to self-administer Hizentra by infusing under the skin. Patient support for this drug is provided by CSL Behring.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/11

HCPCS Effective Date:

1/1/11

HCPCS Short Description:

Hizentra injection

Billing and Coding Guide:

https://labeling.cslbehring.com/PRODUCT-DOCUMENT/US/Hizentra/EN/Hizentra-Coding-Guide-PI-v2.pdf, https://labeling.cslbehring.com/PRODUCT-DOCUMENT/US/Hizentra/EN/Hizentra-Coding-Guide-CIDP-v2.pdf

Patient Assistance:

https://www.hizentra.com/hcp/hizentra-connect-support

HIZENTRA - J1559